DK117957B - Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener. - Google Patents

Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.

Info

Publication number
DK117957B
DK117957B DK273366AA DK273366A DK117957B DK 117957 B DK117957 B DK 117957B DK 273366A A DK273366A A DK 273366AA DK 273366 A DK273366 A DK 273366A DK 117957 B DK117957 B DK 117957B
Authority
DK
Denmark
Prior art keywords
oxogona
trienes
alkyl
preparation
Prior art date
Application number
DK273366AA
Other languages
Danish (da)
English (en)
Inventor
R Bucourt
J Tessier
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR974762A external-priority patent/FR1514075A/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK117957B publication Critical patent/DK117957B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes
DK273366AA 1963-02-20 1966-05-27 Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener. DK117957B (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FR925431A FR1426077A (fr) 1963-02-20 1963-02-20 Nouveau dérivé estratriénique et procédé de préparation
FR940549A FR1453214A (fr) 1963-02-20 1963-07-05 Nouveaux dérivés stéroïdes insaturés et procédés de préparation
FR949609A FR3060M (fr) 1963-02-20 1963-10-04 Nouveau médicament doué notamment d'activité hypocholestérolémiante.
FR949608A FR3069M (fr) 1963-02-20 1963-10-04 Nouveau médicament notamment pour le traitement des troubles de l'anabolisme protidique.
BE644138A BE644138A (xx) 1963-02-20 1964-02-20
FR974762A FR1514075A (fr) 1964-02-17 1964-05-15 Nouveau dérivé stéroïde triénique et procédé de préparation
FR985285A FR3804M (fr) 1963-02-20 1964-08-14 Nouveau médicament notamment pour le traitement des troubles dus a une insuffisance de sécrétion du corps jaune.
FR19090A FR1492782A (fr) 1963-02-20 1965-06-01 Nouveau dérivé stéroïde insaturé et procédé de préparation
FR29732A FR5235M (xx) 1963-02-20 1965-08-27

Publications (1)

Publication Number Publication Date
DK117957B true DK117957B (da) 1970-06-22

Family

ID=27575680

Family Applications (1)

Application Number Title Priority Date Filing Date
DK273366AA DK117957B (da) 1963-02-20 1966-05-27 Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.

Country Status (11)

Country Link
US (2) US3248294A (xx)
BE (1) BE644138A (xx)
BR (2) BR6456982D0 (xx)
CH (2) CH429713A (xx)
DE (2) DE1291337B (xx)
DK (1) DK117957B (xx)
FR (8) FR1426077A (xx)
GB (2) GB1048231A (xx)
NL (6) NL6401555A (xx)
OA (2) OA01429A (xx)
SE (3) SE319173B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424745A (en) * 1964-05-27 1969-01-28 Roussel Uclaf Novel process for the preparation of trienic steroid derivatives
US3346454A (en) * 1964-11-04 1967-10-10 Roussel Uclaf 17-alkyl-19-nor-delta4, 9, 11-pregnatriene-3, 20-diones, process and intermediates for preparing same and therapeutic compositions thereof
US3422121A (en) * 1965-08-13 1969-01-14 Merck & Co Inc Process for the preparation of 13-lower alkyl-gona-4,8(14),9-triene-3,17-dione
US3424769A (en) * 1966-04-04 1969-01-28 Syntex Corp Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids
NL129638C (xx) * 1966-08-12
US3461118A (en) * 1966-10-17 1969-08-12 Syntex Corp 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof
US3760073A (en) * 1971-06-09 1973-09-18 Roussel Uclaf Treatment of wounds
FR2162268A1 (en) * 1971-12-08 1973-07-20 Roussel Uclaf 6-alpha, 17-beta-dihydroxy-13-beta-ethyl-17-alpha - -ethynylgona-4,9,11-triene-3-one - with anti oesterogenic anti-lh and
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament
HU201091B (en) * 1985-12-26 1990-09-28 Mitsubishi Chem Ind Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2696641B1 (fr) * 1992-10-13 1997-07-04 Roussel Uclaf Nouvelle utilisation de l'altrenogest.
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
CN101704871B (zh) * 2009-12-01 2012-05-23 北京紫竹药业有限公司 甾体化合物及其用途

Also Published As

Publication number Publication date
OA01428A (fr) 1969-07-04
FR3069M (fr) 1965-01-18
FR1426077A (fr) 1966-01-28
FR1453214A (fr) 1966-06-03
US3257278A (en) 1966-06-21
NL126190C (xx)
SE319173B (xx) 1970-01-12
GB1048231A (en) 1966-11-16
DE1593307A1 (de) 1970-07-23
OA01429A (fr) 1969-07-04
SE323073B (xx) 1970-04-27
FR5235M (xx) 1967-07-17
NL6615432A (xx) 1967-01-25
SE323071B (xx) 1970-04-27
BE644138A (xx) 1964-08-20
FR2713M (fr) 1964-08-10
FR3060M (fr) 1965-01-11
GB1048232A (en) 1966-11-16
NL6401555A (xx) 1964-08-21
BR6456982D0 (pt) 1973-08-14
FR3804M (fr) 1966-01-03
US3248294A (en) 1966-04-26
CH467255A (fr) 1969-01-15
BR6680069D0 (pt) 1973-12-26
NL6607609A (xx) 1966-12-02
CH429713A (fr) 1967-02-15
DE1291337B (de) 1969-03-27
NL124135C (xx)
NL127247C (xx)
FR1492782A (fr) 1967-08-25

Similar Documents

Publication Publication Date Title
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK108500C (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK117957B (da) Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.
DK111889B (da) Fremgangsmåde til fremstilling af 3-N-substituerede tricycloundecaner.
DK106185C (da) Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner.
DK120596B (da) Fremgangsmåde til fremstilling af acetoxymethylbenzylpenicillinat.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.
DK104461C (da) Fremgangsmåde til fremstilling af 3-amino-isoxazoler.
DK108004C (da) Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril.
DK107031C (da) Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider.
DK106328C (da) Fremgangsmåde til fremstilling af 17α-alkoxy-16-methylen-3,20-diketopregnanderivater.
DK105592C (da) Fremgangsmåde til fremstilling af substituerede 5-fluor-pyrimidiner.
DK104571C (da) Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin.
DK115327B (da) Fremgangsmåde til fremstilling af hydroxyphenylalkylphosphonater.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK109260C (da) Fremgangsmåde til fremstilling af 3,5-diklor-2, 6-dimetyl-4-pyridinol.
DK113991B (da) Fremgangsmåde til fremstilling af 2-chlor-3-oxo-butanamider.
DK122883B (da) Fremgangsmåde til fremstilling af ω-lactamer.
DK109895C (da) Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner.
DK114904B (da) Fremgangsmåde til fremstilling af 3,5-diiodthyroniner.
DK108153C (da) Fremgangsmåde til fremstilling af 1-alkyl-5-nitroimidazol-2-carboxylater.
DK105983C (da) Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK120764B (da) Fremgangsmåde til fremstilling af 2-amino-5-nitro-benzophenoner.
DK129243B (da) Fremgangsmåde til fremstilling af 6-demetyltetracykliner.